CVS struggled financially last year after underpricing some Aetna insurance plans and the government lowered quality ratings.

CVS Health Corporation reported financial results for the fourth quarter and full year of 2024, highlighting challenges within its insurance segment. The company’s Aetna health insurance unit experienced increased medical costs and lower Medicare Advantage star ratings, which affected overall profitability.

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $60.0 to $80.0 for CVS Health over the last 3 months.

CVS Health has eliminated more than 1,000 jobs based at or reporting to its offices in Hartford, which include the headquarters of Aetna.

After underperforming throughout 2024, shares of CVS Health (NYSE: CVS) are surging. From the end of 2024 through Feb. 14, the stock climbed 46.7% higher. Shares of the healthcare conglomerate stock notched significant gains after management presented an encouraging fourth-quarter earnings report on Wednesday,

Aetna and the University of Texas Medical Branch have reached an agreement to bring customers of the CVS-owned health insurance company back in-network.

CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings surpassing analysts’

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

today announces a collaboration with Aetna Better Health® of Illinois, a CVS Health® company (NYSE: CVS). Aetna Better Health of Illinois members can now use Twentyeight Health to connect with ...